Several lines of evidence from patients with attention deficit hyperactivity disorder (ADHD) indicated that decreased midbrain BDNF activity might be implicated in the pathogenesis of attention deficits, while pharmacotherapy for ADHD upregulated BDNF expression in the brain (47, 48). Here, BDNF is linked to attention deficit-hyperactivity disorder.